1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Global Top 10 Pharmaceutical Companies: Company Guide

Global Top 10 Pharmaceutical Companies: Company Guide

  • June 2014
  • -
  • Global Data
  • -
  • 487 pages

Synopsis

The ICD Research Global Top 10 Pharmaceutical Companies: Company Guide is a crucial resource for anyone looking to gain information on the top companies in the global pharmaceutical industry. Detailed company profile and SWOT analysis information is provided for all the leading companies who are ranked in order by total annual revenues generated.

Johnson & Johnson
Pfizer Inc.
Novartis AG
Bayer AG
Merck & Co., Inc.
Sanofi S.A.
GlaxoSmithKline plc
AstraZeneca PLC
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.

ICD Research's Global Top 10 Pharmaceutical Companies: Company Guide report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Summary

This report presents key information and issues for all the leading companies in the global pharmaceutical industry for business intelligence requirements. It also provides information on business operations, history, major products and services, prospects, key competitors, key employees, locations and subsidiaries for the companies featured within the report. In addition, the report also provides strengths, weaknesses, opportunities (growth potential) and threats (competition) for all the leading companies in the industry. All strategic and operational business information is objectively reported.

Scope

• The ICD Research Global Top 10 Pharmaceutical Companies: Company Guide comprises of two sections – Peer Analysis & Company Profiles. The Peer Analysis section compares key financial parameters for the companies mentioned in the report based on the latest available financial data.

• The Company Profiles section provides in depth data about the featured companies and their operations. The company profiles contain company overview, business description, SWOT analysis, key facts, key employees as well as information on products and services

Reasons To Buy

• Quickly enhance your understanding of the leading companies within the industry and compare them with their peers
• Obtain details and analysis of the market and competitors as well as internal and external factors impacting each individual company featured
• Increase business/sales activities by better understanding your competitors across the industry
• Obtain yearly profitability figures for all the leading companies within the industry

Key Highlights

Johnson & Johnson, is the largest of all pharmaceutical companies with revenues of US$67224 million reported in FY2013. The second- and third-largest pharmaceutical companies are Pfizer Inc. and Novartis AG with revenues of US$58986 million and US$57561 million respectively in FY2013.

Table Of Contents

Global Top 10 Pharmaceutical Companies: Company Guide
Table of Contents
1 PEER LIST
2 Competitive Analysis
3 Company Profile: Johnson and Johnson
3.1 Johnson and Johnson - Company Overview
3.2 Johnson and Johnson - Business Description
3.3 Johnson and Johnson - Major Products and Services
3.4 Johnson and Johnson - History
3.5 Johnson and Johnson - SWOT Analysis
3.6 Johnson and Johnson - Company Information
3.7 Johnson and Johnson - Subsidiaries
3.8 Johnson and Johnson - Financial Ratios
4 Company Profile: Pfizer Inc.
4.1 Pfizer Inc. - Company Overview
4.2 Pfizer Inc. - Business Description
4.3 Pfizer Inc. - Major Products and Services
4.4 Pfizer Inc. - History
4.5 Pfizer Inc. - SWOT Analysis
4.6 Pfizer Inc. - Company Information
4.7 Pfizer Inc. - Subsidiaries
4.8 Pfizer Inc. - Financial Ratios
5 Company Profile: Novartis AG
5.1 Novartis AG - Company Overview
5.2 Novartis AG - Business Description
5.3 Novartis AG - Major Products and Services
5.4 Novartis AG - History
5.5 Novartis AG - SWOT Analysis
5.6 Novartis AG - Company Information
5.7 Novartis AG - Subsidiaries
5.8 Novartis AG - Financial Ratios
6 Company Profile: Bayer AG
6.1 Bayer AG - Company Overview
6.2 Bayer AG - Business Description
6.3 Bayer AG - Major Products and Services
6.4 Bayer AG - History
6.5 Bayer AG - SWOT Analysis
6.6 Bayer AG - Company Information
6.7 Bayer AG - Subsidiaries
6.8 Bayer AG - Financial Ratios
7 Company Profile: Merck and Co., Inc.
7.1 Merck and Co., Inc. - Company Overview
7.2 Merck and Co., Inc. - Business Description
7.3 Merck and Co., Inc. - Major Products and Services
7.4 Merck and Co., Inc. - History
7.5 Merck and Co., Inc. - SWOT Analysis
7.6 Merck and Co., Inc. - Company Information
7.7 Merck and Co., Inc. - Subsidiaries
7.8 Merck and Co., Inc. - Financial Ratios
8 Company Profile: Sanofi
8.1 Sanofi - Company Overview
8.2 Sanofi - Business Description
8.3 Sanofi - Major Products and Services
8.4 Sanofi - History
8.5 Sanofi - SWOT Analysis
8.6 Sanofi - Company Information
8.7 Sanofi - Subsidiaries
8.8 Sanofi - Financial Ratios
9 Company Profile: GlaxoSmithKline plc
9.1 GlaxoSmithKline plc - Company Overview
9.2 GlaxoSmithKline plc - Business Description
9.3 GlaxoSmithKline plc - Major Products and Services
9.4 GlaxoSmithKline plc - History
9.5 GlaxoSmithKline plc - SWOT Analysis
9.6 GlaxoSmithKline plc - Company Information
9.7 GlaxoSmithKline plc - Other Locations and Subsidiaries
9.8 GlaxoSmithKline plc - Financial Ratios
10 Company Profile: AstraZeneca PLC
10.1 AstraZeneca PLC - Company Overview
10.2 AstraZeneca PLC - Business Description
10.3 AstraZeneca PLC - Major Products and Services
10.4 AstraZeneca PLC - History
10.5 AstraZeneca PLC - SWOT Analysis
10.6 AstraZeneca PLC - Company Information
10.7 AstraZeneca PLC - Subsidiaries
10.8 AstraZeneca PLC - Financial Ratios
11 Company Profile: Eli Lilly and Company
11.1 Eli Lilly and Company - Company Overview
11.2 Eli Lilly and Company - Business Description
11.3 Eli Lilly and Company - Major Products and Services
11.4 Eli Lilly and Company - History
11.5 Eli Lilly and Company - SWOT Analysis
11.6 Eli Lilly and Company - Company Information
11.7 Eli Lilly and Company - Subsidiaries
11.8 Eli Lilly and Company - Financial Ratios
12 Company Profile: F. Hoffmann-La Roche Ltd.
12.1 F. Hoffmann-La Roche Ltd. - Company Overview
12.2 F. Hoffmann-La Roche Ltd. - Business Description
12.3 F. Hoffmann-La Roche Ltd. - Major Products and Services
12.4 F. Hoffmann-La Roche Ltd. - History
12.5 F. Hoffmann-La Roche Ltd. - SWOT Analysis
12.6 F. Hoffmann-La Roche Ltd. - Company Information
12.7 F. Hoffmann-La Roche Ltd. - Subsidiaries
13 Appendix

List of Tables

Table 1: Global Top 10 Pharmaceutical Companies - Peer List
Table 2: Johnson and Johnson - Key Facts
Table 3: Johnson and Johnson - Major Products and Services
Table 4: Johnson and Johnson - History
Table 5: Johnson and Johnson - Key Employees
Table 6: Johnson and Johnson - Key Employee Biographies
Table 7: Johnson and Johnson - Subsidiaries
Table 8: Johnson and Johnson - Capital Market Ratios
Table 9: Johnson and Johnson - Annual Ratios
Table 10: Johnson and Johnson - Key Interim Ratios
Table 11: Pfizer Inc. - Key Facts
Table 12: Pfizer Inc. - Major Products and Services
Table 13: Pfizer Inc. - History
Table 14: Pfizer Inc. - Key Employees
Table 15: Pfizer Inc. - Key Employee Biographies
Table 16: Pfizer Inc. - Subsidiaries
Table 17: Pfizer Inc. - Capital Market Ratios
Table 18: Pfizer Inc. - Annual Ratios
Table 19: Pfizer Inc. - Key Interim Ratios
Table 20: Novartis AG - Key Facts
Table 21: Novartis AG - Major Products and Services
Table 22: Novartis AG - History
Table 23: Novartis AG - Key Employees
Table 24: Novartis AG - Key Employee Biographies
Table 25: Novartis AG - Subsidiaries
Table 26: Novartis AG - Capital Market Ratios
Table 27: Novartis AG - Annual Ratios
Table 28: Novartis AG - Key Interim Ratios
Table 29: Bayer AG - Key Facts
Table 30: Bayer AG - Major Products and Services
Table 31: Bayer AG - History
Table 32: Bayer AG - Key Employees
Table 33: Bayer AG - Key Employee Biographies
Table 34: Bayer AG - Subsidiaries
Table 35: Bayer AG - Capital Market Ratios
Table 36: Bayer AG - Annual Ratios
Table 37: Bayer AG Key Ratios - Interim
Table 38: Merck and Co., Inc. - Key Facts
Table 39: Merck and Co., Inc. - Major Products and Services
Table 40: Merck and Co., Inc. - History
Table 41: Merck and Co., Inc. - Key Employees
Table 42: Merck and Co., Inc. - Key Employee Biographies
Table 43: Merck and Co., Inc. - Subsidiaries
Table 44: Merck and Co., Inc. - Key Capital Market Indicators
Table 45: Merck and Co., Inc. - Annual Ratios
Table 46: Merck and Co., Inc. Key Interim Ratios
Table 47: Sanofi - Key Facts
Table 48: Sanofi - Major Products and Services
Table 49: Sanofi - History
Table 50: Sanofi - Key Employees
Table 51: Sanofi - Key Employee Biographies
Table 52: Sanofi - Subsidiaries
Table 53: Sanofi - Key Capital Market Indicators
Table 54: Sanofi - Annual Ratios
Table 55: Sanofi Key Interim Ratios
Table 56: GlaxoSmithKline plc - Key Facts
Table 57: GlaxoSmithKline plc - Major Products and Services
Table 58: GlaxoSmithKline plc - History
Table 59: GlaxoSmithKline plc - Key Employees
Table 60: GlaxoSmithKline plc - Key Employee Biographies
Table 61: GlaxoSmithKline plc - Subsidiaries
Table 62: GlaxoSmithKline plc - Key Capital Market Indicators
Table 63: GlaxoSmithKline plc - Annual Ratios
Table 64: GlaxoSmithKline plc Key Interim Ratios
Table 65: AstraZeneca PLC - Key Facts
Table 66: AstraZeneca PLC - Major Products and Services
Table 67: AstraZeneca PLC - History
Table 68: AstraZeneca PLC - Key Employees
Table 69: AstraZeneca PLC - Key Employee Biographies
Table 70: AstraZeneca PLC - Subsidiaries
Table 71: AstraZeneca PLC - Key Capital Market Indicators
Table 72: AstraZeneca PLC - Annual Ratios
Table 73: AstraZeneca PLC Key Interim Ratios
Table 74: Eli Lilly and Company - Key Facts
Table 75: Eli Lilly and Company - Major Products and Services
Table 76: Eli Lilly and Company - History
Table 77: Eli Lilly and Company - Key Employees
Table 78: Eli Lilly and Company - Key Employee Biographies
Table 79: Eli Lilly and Company - Subsidiaries
Table 80: Eli Lilly and Company - Key Capital Market Indicators
Table 81: Eli Lilly and Company - Annual Ratios
Table 82: Eli Lilly and Company Key Interim Ratios
Table 83: F. Hoffmann-La Roche Ltd. - Key Facts
Table 84: F. Hoffmann-La Roche Ltd. - Major Products and Services
Table 85: F. Hoffmann-La Roche Ltd. - History
Table 86: F. Hoffmann-La Roche Ltd. - Key Employees
Table 87: F. Hoffmann-La Roche Ltd. - Key Employee Biographies
Table 88: F. Hoffmann-La Roche Ltd. - Subsidiaries

List of Figures

Figure 1: Global Top 10 Pharmaceutical Companies - Revenue and Operating Margin (2012)
Figure 2: Global Top 10 Pharmaceutical Companies - Liquidity (2012)
Figure 3: Global Top 10 Pharmaceutical Companies - Valuation (2012)
Figure 4: Global Top 10 Pharmaceutical Companies - Turnover: Inventory and Asset (2012)
Figure 5: Global Top 10 Pharmaceutical Companies - Market Capitalization
Figure 6: Johnson and Johnson - Revenue and Operating Profit
Figure 7: Johnson and Johnson - Solvency
Figure 8: Johnson and Johnson - Valuation
Figure 9: Johnson and Johnson - Assets and Liabilities
Figure 10: Johnson and Johnson - Net Debt Vs Gearing Ratio
Figure 11: Pfizer Inc. - Revenue and Operating Profit
Figure 12: Pfizer Inc. - Solvency
Figure 13: Pfizer Inc. - Valuation
Figure 14: Pfizer Inc. - Assets and Liabilities
Figure 15: Novartis AG - Revenue and Operating Profit
Figure 16: Novartis AG - Solvency
Figure 17: Novartis AG - Valuation
Figure 18: Novartis AG - Assets and Liabilities
Figure 19: Novartis AG - Net Debt Vs Gearing Ratio
Figure 20: Bayer AG - Revenue and Operating Profit
Figure 21: Bayer AG - Solvency
Figure 22: Bayer AG - Valuation
Figure 23: Bayer AG - Assets and Liabilities
Figure 24: Bayer AG - Net Debt Vs Gearing Ratio
Figure 25: Merck and Co., Inc. - Revenue and Operating Profit
Figure 26: Merck and Co., Inc. - Solvency
Figure 27: Merck and Co., Inc. - Valuation
Figure 28: Merck and Co., Inc. - Assets and Liabilities
Figure 29: Merck and Co., Inc. - Net Debt Vs Gearing Ratio
Figure 30: Sanofi - Revenue and Operating Profit
Figure 31: Sanofi - Solvency
Figure 32: Sanofi - Valuation
Figure 33: Sanofi - Assets and Liabilities
Figure 34: Sanofi - Net Debt Vs Gearing Ratio
Figure 35: GlaxoSmithKline plc - Revenue and Operating Profit
Figure 36: GlaxoSmithKline plc - Solvency
Figure 37: GlaxoSmithKline plc - Valuation
Figure 38: GlaxoSmithKline plc - Assets and Liabilities
Figure 39: GlaxoSmithKline plc - Net Debt Vs Gearing Ratio
Figure 40: AstraZeneca PLC - Revenue and Operating Profit
Figure 41: AstraZeneca PLC - Solvency
Figure 42: AstraZeneca PLC - Valuation
Figure 43: AstraZeneca PLC - Assets and Liabilities
Figure 44: AstraZeneca PLC - Net Debt Vs Gearing Ratio
Figure 45: Eli Lilly and Company - Revenue and Operating Profit
Figure 46: Eli Lilly and Company - Solvency
Figure 47: Eli Lilly and Company - Valuation
Figure 48: Eli Lilly and Company - Assets and Liabilities
Figure 49: Eli Lilly and Company - Net Debt Vs Gearing Ratio

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.